Co-Authors
This is a "connection" page, showing publications co-authored by Massimo Galli and Antonio Di Sabatino.
Connection Strength
0.169
-
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population. Dig Liver Dis. 2021 03; 53(3):263-270.
Score: 0.058
-
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study. Diabetes Care. 2020 12; 43(12):2999-3006.
Score: 0.057
-
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19. Acta Diabetol. 2020 Jul; 57(7):779-783.
Score: 0.055